Barclays PLC Sells 234,757 Shares of Enhabit, Inc. (NYSE:EHAB)

Barclays PLC lessened its position in Enhabit, Inc. (NYSE:EHAB - Free Report) by 74.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 79,321 shares of the company's stock after selling 234,757 shares during the period. Barclays PLC owned 0.16% of Enhabit worth $627,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Geode Capital Management LLC increased its holdings in Enhabit by 0.9% during the 3rd quarter. Geode Capital Management LLC now owns 1,137,458 shares of the company's stock valued at $8,987,000 after purchasing an additional 10,538 shares during the period. Y Intercept Hong Kong Ltd purchased a new position in shares of Enhabit during the third quarter valued at approximately $450,000. XTX Topco Ltd bought a new position in shares of Enhabit during the third quarter valued at approximately $123,000. Zacks Investment Management purchased a new stake in Enhabit in the third quarter worth $107,000. Finally, Jane Street Group LLC boosted its holdings in Enhabit by 514.3% in the third quarter. Jane Street Group LLC now owns 901,084 shares of the company's stock valued at $7,119,000 after acquiring an additional 754,395 shares in the last quarter.

Insider Buying and Selling

In other news, Director Jeffrey Bolton acquired 4,000 shares of Enhabit stock in a transaction on Thursday, December 12th. The stock was acquired at an average cost of $8.69 per share, for a total transaction of $34,760.00. Following the purchase, the director now owns 98,144 shares in the company, valued at $852,871.36. This trade represents a 4.25 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Stuart M. Mcguigan bought 15,000 shares of the company's stock in a transaction dated Tuesday, December 10th. The stock was purchased at an average price of $8.81 per share, for a total transaction of $132,150.00. Following the purchase, the director now owns 46,810 shares of the company's stock, valued at approximately $412,396.10. This represents a 47.15 % increase in their position. The disclosure for this purchase can be found here. 1.90% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities research analysts have recently commented on EHAB shares. Leerink Partners reaffirmed a "market perform" rating and issued a $8.00 target price (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. Jefferies Financial Group upgraded shares of Enhabit from a "hold" rating to a "buy" rating and raised their price objective for the stock from $8.25 to $9.50 in a report on Monday, December 9th. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, Enhabit currently has an average rating of "Hold" and a consensus target price of $8.75.

Enhabit Stock Up 0.2 %

Shares of EHAB stock traded up $0.02 during mid-day trading on Friday, reaching $7.99. 217,365 shares of the company's stock traded hands, compared to its average volume of 244,497. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The company's 50-day moving average price is $7.83 and its 200-day moving average price is $8.11. The company has a market cap of $401.49 million, a P/E ratio of -3.44 and a beta of 1.82. Enhabit, Inc. has a 12 month low of $6.85 and a 12 month high of $11.74.

Enhabit (NYSE:EHAB - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The business had revenue of $253.60 million for the quarter, compared to the consensus estimate of $261.69 million. During the same period in the previous year, the firm earned $0.03 EPS. On average, equities analysts expect that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.